Adjuvant therapy in stage I carcinoma of the breast

Cancer, 04/17/2012

The panel tried to create guidelines for the consideration of adjuvant treatment of these patients, including both hormone and cytotoxic regimens. They also encouraged further research into the molecular analysis of breast cancers and the introduction of clinical trials based on current data, although they concluded that it is too early to add any of those analyses into the decision–making algorithms of recommendations for the treatment of stage I breast cancer.

Print Article Summary Cat 2 CME Report